DARE Dare Bioscience, Inc. - Common Stock
$0,80
Preço · Ago 18, 2026
Fundamentais a partir de Ago 13, 2026
Intervalo 52 Semanas
$1–$4
1% of range
Classificação do Analista
BUY
9 analysts
Preço-Alvo
$10
+1109% upside
P/E (TTM)
-0.7
ROE
270.9%
Margem de Lucro Líquido
-1300.7%
DARE Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.80
Capitalização de Mercado
$12M
P/E (TTM)
-0.7
EPS (TTM)
$-1.20
Receita (TTM)
$1M
Rendimento div.
—
ROE
270.9%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $4
DARE Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$1M
2016-12-31
→
2025-12-31
EPS
$-1.20
2020-12-31
→
2025-12-31
Fluxo de caixa livre
$-10M
2016-12-31
→
2025-12-31
Margens
-1300.7%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DARE
Mediana de Pares
P/E (TTM)
-0.7
53.4
P/S (TTM)
11.3
17.7
P/B
4.1
4.8
Price / FCF (Preço / FCF)
-1.1
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DARE
Mediana de Pares
Operating Margin (Margem Operacional)
-1315.5%
—
Net Profit Margin (Margem de Lucro Líquido)
-1300.7%
-280.9%
ROA
-49.1%
-28.2%
ROE
270.9%
-50.7%
ROIC
-476.8%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DARE
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
1.1
1.7
Quick Ratio (Índice de Liquidez Seca)
1.0
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DARE
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
10429.4%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-53.1%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DARE
Mediana de Pares
DARE Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
9 analistas
- Compra forte 2 22,2%
- Compra 6 66,7%
- Manter 1 11,1%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
3 analistas · 2026-08-15
Mediana
$9.00
Média
$9.67
← Abaixo de todos os alvos
$0.80
Mín
$8.00
Máx
$12.00
Alvo mediano
$9.00
+1025,7%
Alvo médio
$9.67
+1109,1%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.12%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Março de 2026 | $-0.20 | $-0.30 | 0.10% |
| 31 de Dezembro de 2025 | $-0.02 | $-0.44 | 0.42% |
| 30 de Setembro de 2025 | $-0.28 | $-0.36 | 0.08% |
| 30 de Junho de 2025 | $-0.45 | $-0.59 | 0.14% |
| 31 de Março de 2025 | $-0.50 | $-0.59 | 0.09% |
| 31 de Dezembro de 2024 | $-0.65 | $-0.54 | -0.11% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| BFRI | — | — | — | — | — | — |
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| ADIL | $244.4K | -0.0 | — | — | -146.8% | — |
| CNSP | — | -0.1 | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Cost of Revenue | $295.8K | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $14M | $22M | $30M | $31M | $21M | $9M | $6M | $984.7K | $72.7K | $26M | $12M | |
| SG&A Expense | $9M | $9M | $12M | $11M | $8M | $7M | $5M | $5M | $3M | $157.9K | $11M | $9M | |
| Operating Expenses | $14M | $23M | $34M | $41M | $39M | $27M | $14M | $17M | $11M | $630.6K | $37M | $20M | |
| Operating Income | $-14M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | $-11M | $-630.6K | · | · | |
| Interest Expense | · | · | · | · | · | · | · | · | $322.6K | $42.1K | $2M | $1M | |
| Interest Income | · | · | · | · | · | · | · | · | · | $86.0K | $10.0K | $9.0K | |
| Other Non-op | $-153.1K | $981.5K | $778.5K | $437.8K | $2.5K | $1.5K | $81.0K | $143.5K | $-322.6K | $-2M | $-2M | $-3M | |
| Pretax Income | $-14M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-673.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.2K | $0 | · | · | · | |
| Net Income | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| EPS (Basic) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 | $-0.91 | · | · | · | · | · | · | |
| Shares (Basic) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| Shares (Diluted) | 11,178,752 | 8,497,459 | 7,275,308 | 84,571,805 | 61,154,157 | 30,091,469 | · | · | 3,232,278 | 835,000 | · | · | |
| EBITDA | $-12M | $-23M | $-31M | $-31M | $-39M | $-27M | $-14M | $-17M | · | $261.0K | $192.0K | $126.0K |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $16M | $10M | $35M | $52M | $5M | $5M | $7M | $8M | $44.6K | $219.4K | $51M | |
| Receivables | · | · | · | · | $0 | · | · | · | · | $823.0K | · | · | |
| Prepaid Expense | $387.1K | $3M | $6M | $7M | $2M | $2M | $1M | $403.1K | $311.6K | $1M | · | · | |
| Other Current Assets | $573.1K | $0 | $0 | $0 | · | · | · | $0 | $193.5K | · | · | · | |
| Current Assets | $27M | $18M | $18M | $43M | $55M | $7M | $6M | $7M | $8M | $44.6K | $77M | $53M | |
| PP&E (Net) | $2M | $1M | $656.0K | $64.9K | $26.0K | $37.9K | $63.5K | $9.4K | $0 | $668.0K | $576.0K | $342.0K | |
| PP&E (Gross) | $2M | $2M | $801.7K | · | · | · | · | · | · | $2M | $2M | $2M | |
| Accum. Depreciation | $338.0K | $175.9K | $145.7K | · | · | · | · | · | · | $1M | $1M | $1M | |
| Goodwill | · | · | · | · | · | · | · | $0 | $5M | · | · | · | |
| Other Non-current Assets | $1M | $1M | $599.6K | $254.3K | $485.1K | $528.9K | $935.3K | $578.0K | $723.2K | $12.7K | $347.0K | $215.0K | |
| Total Assets | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Accounts Payable | $1M | $1M | $3M | $2M | $2M | $1M | $1M | $459.7K | $308.2K | $12.7K | $2M | $1M | |
| Accrued Liabilities | $725.2K | $3M | $3M | $11M | $3M | $3M | $2M | $631.4K | $658.4K | $5M | $6M | $4M | |
| Short-term Debt | · | · | · | · | $0 | $367.3K | $0 | · | · | · | · | · | |
| Current Liabilities | $24M | $22M | $20M | $32M | $16M | $8M | $6M | $1M | $966.7K | $755.2K | $16M | $8M | |
| Capital Leases | $559.4K | $754.4K | $935.7K | $90.3K | $0 | $41.8K | $389.6K | $389.0K | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | $0 | $41.8K | $389.6K | $9.7K | · | $1M | $473.0K | $7.0K | |
| Total Liabilities | $30M | $28M | $26M | $33M | $17M | $9M | $7M | $1M | $967.0K | $755.2K | · | · | |
| Total Debt | · | · | · | · | $0 | $367.3K | · | · | · | · | · | · | |
| Common Stock | $1.4K | $870 | $833 | $8.5K | $8.4K | $4.2K | $2.0K | $1.1K | $605 | $91 | $3.0K | $2.0K | |
| Paid-in Capital | $192M | · | · | · | · | · | · | · | · | · | · | $167M | |
| Retained Earnings | $-189M | $-175M | $-171M | $-141M | $-110M | $-71M | $-44M | $-29M | $-12M | $-727.8K | $-161M | $-122M | |
| AOCI | $-421.6K | $-428.8K | $-360.9K | $-351.3K | $-155.0K | $-91.4K | $-102.6K | $-96.7K | $-18.1K | · | · | · | |
| Stockholders' Equity | $3M | $-6M | $-5M | $11M | $39M | $-1M | $440.8K | $7M | $13M | $-710.6K | $-46.9K | $45M | |
| Liabilities + Equity | $32M | $22M | $21M | $44M | $56M | $8M | $7M | $8M | $14M | $44.6K | $78M | $53M | |
| Shares Outstanding | 14,499,502 | 8,700,386 | 8,331,161 | 7,068,790 | 83,944,119 | 41,596,253 | 19,683,401 | 11,422,161 | 6,047,161 | 910,000 | 27,346,780 | 20,125,049 |
Fluxo de Caixa 11
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $42.3K | · | · | · | · | · | · | · | $261.0K | $192.0K | $126.0K | |
| Stock-based Comp | $1M | $2M | $3M | $2M | $2M | $742.0K | $462.2K | $139.3K | $15.8K | $9.0K | $2M | $885.0K | |
| Other Non-cash | $382.4K | · | · | · | · | · | · | · | · | $3M | $5M | $3M | |
| Operating Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | $-3M | $-372.3K | $-32M | $-19M | |
| CapEx | $385.3K | $573.0K | $629.4K | $63.1K | $14.5K | $17.6K | $0 | $11.8K | $0 | $535.0K | $277.0K | $225.0K | |
| Investing Cash Flow | $-385.3K | $-573.0K | $-629.4K | $-63.1K | $-14.5K | $-17.6K | $6M | $-518.8K | $10M | · | · | · | |
| Stock Issued | $21M | $453.6K | · | $1M | $16M | $23M | $5M | · | · | $918.0K | $3M | $140.0K | |
| Net Stock Activity | $21M | · | · | $1M | $16M | $23M | · | · | · | $918.0K | $3M | $140.0K | |
| Financing Cash Flow | $19M | $354.5K | $16M | $1M | $76M | $25M | $5M | $10M | $155.0K | · | · | · | |
| Net Change in Cash | $9M | $5M | $-24M | $-17M | $47M | $-110.6K | $-2M | $-754.0K | $8M | $-174.8K | $25M | $46M | |
| Free Cash Flow | $-10M | $5M | $-39M | $-18M | $-29M | $-25M | $-13M | $-10M | · | $-34M | $-32M | $-19M |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1315.5% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | · | · | · | |
| Net Margin | -1300.7% | -41430.9% | -1074.2% | -309.5% | · | · | · | · | · | -5131.2% | · | -29177.5% | |
| Pretax Margin | -1314.4% | -41414.6% | -1074.1% | -309.5% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1156.9% | -239692.2% | -1101.9% | -313.9% | · | · | · | · | · | 34.1% | · | 157.5% | |
| ROA | -49.1% | -18.7% | -92.7% | -62.1% | -122.2% | -365.5% | -186.8% | -151.6% | · | -67.8% | -60.2% | -77.5% | |
| ROE | 270.9% | 108.1% | 822.2% | -165.2% | -109.5% | 2159.6% | -1267.4% | -205.3% | · | -601.7% | -84.2% | 95.3% | |
| ROIC | -476.8% | 390.1% | 613.0% | -282.4% | -100.8% | 3493.2% | -3254.1% | -251.0% | · | · | · | · |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 | 0.9 | 1.1 | 6.6 | · | 2.2 | 4.7 | 6.6 | |
| Quick Ratio | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 | 0.6 | 0.9 | 6.2 | · | 2.1 | 4.6 | 6.3 | |
| Debt / Equity | · | · | · | · | 0.0 | -0.3 | · | · | · | · | · | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.2 | · | · | · | · | · | 0.0 | · | 0.0 |
Taxas de Crescimento 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10429.4% | -99.7% | -71.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -53.1% | · | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $9.8K | $3M | $10M | $0 | · | · | · | · | $766.0K | · | $80.0K | |
| Net Income TTM | $-13M | $-4M | $-30M | $-31M | $-39M | $-27M | $-14M | $-17M | $-12M | $-672.7K | $-40M | $-23M | |
| Market Cap | $28M | $27M | $371M | $845M | $2.01B | $669M | $194M | $97M | · | $2.46B | $9.19B | $15.02B | |
| Enterprise Value | · | · | · | · | $1.96B | $665M | · | · | · | · | · | · | |
| P/E | -1.6 | -6.5 | -0.9 | -26.9 | -38.1 | -17.7 | · | · | · | · | · | · | |
| P/S | 27.2 | 2774.4 | 132.0 | 84.5 | · | · | · | · | · | 3209.5 | · | 187766.7 | |
| P/B | 9.8 | -4.5 | -73.4 | 76.0 | 52.0 | -580.7 | 439.4 | 14.5 | · | 187.5 | 188.5 | 331.4 | |
| P / Tangible Book | 9.8 | · | · | 76.0 | 52.0 | · | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | 5.0 | -9.5 | -46.7 | -70.0 | -26.5 | -14.5 | -9.5 | · | -73.3 | -287.9 | -788.1 | |
| P / FCF | -2.7 | 5.6 | -9.4 | -46.5 | -70.0 | -26.5 | -14.5 | -9.5 | · | -72.2 | -285.4 | -778.9 | |
| EV / EBITDA | · | · | · | · | -50.2 | -24.3 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -68.2 | -26.3 | · | · | · | · | · | · | |
| Earnings Yield | -62.2% | -15.4% | -111.9% | -3.7% | -2.6% | -5.7% | · | · | · | · | · | · |
Demonstração de Resultados 13
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $187.5K | $152.5K | $1M | $2.3K | $-21.2K | $25.4K | $-63.6K | $41.7K | $22.4K | $9.3K | $2M | $1M | $0 | $0 | $0 | $0 | |
| Cost of Revenue | $319.9K | $242.3K | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $242.0K | $660.5K | $622.0K | $1M | $1M | $2M | $3M | $3M | $5M | $3M | $4M | $7M | $6M | $5M | $13M | $4M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $3M | $3M | $2M | $4M | $4M | $5M | $5M | $5M | $7M | $6M | $7M | $9M | $9M | $8M | $16M | $7M | |
| Operating Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-5M | $-5M | $-5M | $-7M | $-6M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| Other Non-op | $-14.8K | $-991 | $-276.6K | $109.4K | $-188.7K | $202.8K | $2M | $-21.2K | $-109.3K | $-732.9K | $113.9K | $97.3K | $227.1K | $340.1K | $287.3K | $119.0K | |
| Net Income | $-3M | $-3M | $-1M | $-4M | $-4M | $-4M | $-6M | $-5M | $13M | $-7M | $-5M | $-8M | $-9M | $-8M | $-16M | $-7M | |
| EPS (Basic) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.65 | $-0.55 | $1.53 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| EPS (Diluted) | $-0.20 | $-0.21 | $0.03 | $-0.28 | $-0.45 | $-0.50 | $-0.64 | $-0.55 | $1.52 | $-0.81 | $-1.75 | $-1.09 | $-1.22 | $-0.09 | $-0.19 | $-0.08 | |
| Shares (Basic) | 14,889,832 | 14,522,835 | -19,206,568 | 12,755,112 | 8,871,155 | 8,759,053 | -16,824,405 | 8,534,433 | 8,411,242 | 8,376,189 | -93,030,129 | 7,587,637 | 7,200,260 | 85,517,540 | -168,877,595 | 84,822,516 | |
| Shares (Diluted) | 14,889,832 | 14,522,835 | -19,206,568 | 12,755,112 | 8,871,155 | 8,759,053 | -16,889,394 | 8,534,433 | 8,476,231 | 8,376,189 | -93,030,129 | 7,587,637 | 7,200,260 | 85,517,540 | -169,564,254 | 84,822,516 | |
| EBITDA | $-3M | $-2M | · | $-4M | $-4M | $-4M | · | $-5M | $-7M | $-6M | · | $-8M | $-9M | $-8M | · | $-7M |
Balanço Patrimonial 22
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $19M | $25M | $23M | $5M | $10M | $16M | $11M | $16M | $4M | $10M | $14M | $13M | $20M | $35M | $40M | |
| Prepaid Expense | $835.4K | $680.8K | $2M | $2M | $1M | $1M | $3M | $3M | $4M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | |
| Other Current Assets | $456.4K | $687.8K | · | $53.2K | · | · | · | · | · | $152.2K | · | $831.4K | $272.1K | $201.4K | · | · | |
| Current Assets | $17M | $22M | $27M | $25M | $7M | $12M | $18M | $15M | $21M | $10M | $18M | $22M | $22M | $30M | $43M | $50M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $706.3K | $322.3K | $52.5K | $656.0K | $58.6K | $45.8K | $55.4K | $64.9K | $72.8K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $2M | · | · | · | $801.7K | · | · | · | · | · | |
| Accum. Depreciation | · | · | $338.0K | · | · | · | $175.9K | · | · | · | $145.7K | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $533.9K | $528.6K | $654.5K | $599.6K | $796.4K | $920.9K | $799.3K | $254.3K | $736.5K | |
| Total Assets | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Accounts Payable | $762.9K | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $4M | $3M | $5M | $7M | $3M | $2M | $3M | |
| Accrued Liabilities | $448.9K | $529.3K | $725.2K | $2M | $3M | $2M | $3M | $2M | $1M | $1M | $3M | $5M | $4M | $5M | $11M | $4M | |
| Current Liabilities | $17M | $21M | $24M | $21M | $19M | $21M | $22M | $13M | $15M | $18M | $20M | $26M | $25M | $24M | $32M | $23M | |
| Capital Leases | $273.9K | $418.3K | $559.4K | $288.6K | $448.2K | $603.3K | $754.4K | $897.8K | $1M | $1M | $935.7K | $0 | $23.3K | $57.1K | $90.3K | $194.6K | |
| Total Liabilities | $23M | $27M | $30M | $28M | $26M | $28M | $28M | $20M | $21M | $24M | $26M | $27M | $26M | $25M | $33M | $24M | |
| Total Debt | · | · | · | $10.5K | $188.0K | $91.9K | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.5K | $1.5K | $1.4K | $1.4K | $903 | $885 | $870 | $854 | $854 | $10.1K | $833 | $9.8K | $8.7K | $8.6K | $8.5K | $8.5K | |
| Paid-in Capital | $194M | $193M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-195M | $-192M | $-189M | $-187M | $-184M | $-180M | $-175M | $-170M | $-165M | $-178M | $-171M | $-166M | $-158M | $-149M | $-141M | $-125M | |
| AOCI | $-374.9K | $-377.1K | $-421.6K | $-396.0K | $-402.8K | $-415.7K | $-428.8K | $-362.6K | $-385.6K | $-400.1K | $-360.9K | $-419.5K | $-404.5K | $-373.3K | $-351.3K | $-530.7K | |
| Stockholders' Equity | $-560.1K | $734.5K | $3M | $3M | $-13M | $-10M | $-6M | $-1M | $3M | $-11M | $-5M | $-2M | $-3M | $5M | $11M | $26M | |
| Liabilities + Equity | $22M | $28M | $32M | $31M | $13M | $19M | $22M | $18M | $24M | $13M | $21M | $25M | $23M | $30M | $44M | $50M | |
| Shares Outstanding | 15,169,502 | 14,559,502 | 14,499,502 | 13,929,502 | 9,030,386 | 8,850,386 | 8,700,386 | 8,546,364 | 8,546,361 | 100,581,900 | 8,331,161 | 98,292,344 | 86,633,588 | 86,178,996 | 84,825,481 | 83,944,119 |
Fluxo de Caixa 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $572.1K | $554.6K | $534.4K | $481.9K | $460.1K | $175.6K | $6.4K | $9.7K | $15.4K | $10.8K | · | · | · | · | · | · | |
| Stock-based Comp | $286.6K | $455.1K | $357.2K | $403.0K | $359.0K | $377.4K | $489.3K | $523.6K | $562.7K | $627.7K | $619.8K | $636.1K | $650.2K | $624.6K | $532.1K | $556.4K | |
| Other Non-cash | · | $-4M | · | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-7M | $-6M | $1M | $-442.1K | $-5M | $-5M | $5M | $-6M | $13M | $-7M | $-8M | $-8M | $-7M | $-16M | $-6M | $9M | |
| CapEx | $80.6K | $0 | $206.6K | $174.7K | $-153.4K | $157.3K | $562.8K | $-282.3K | $285.2K | $7.3K | $607.3K | $22.1K | $0 | $0 | $2.7K | $55.0K | |
| Investing Cash Flow | $-80.6K | $0 | $-206.6K | $-174.7K | $153.4K | $-157.3K | $-562.8K | $282.3K | $-285.2K | $-7.3K | $-607.3K | $-22.1K | $0 | $0 | $-2.7K | $-55.0K | |
| Stock Issued | $166.7K | $94.9K | · | · | $475.0K | $436.2K | · | · | · | · | · | · | · | · | · | $0 | |
| Net Stock Activity | · | $94.9K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $951.2K | $-715.5K | $424.1K | $19M | $-43.8K | $246.6K | $-211.3K | $436.4K | $115.4K | $14.0K | $5M | $9M | $452.2K | $1M | $-1 | $4.5K | |
| Net Change in Cash | $-6M | $-6M | $2M | $18M | $-5M | $-5M | $4M | $-5M | $13M | $-7M | $-3M | $565.3K | $-6M | $-15M | $-6M | $8M | |
| Free Cash Flow | · | $-6M | · | · | · | $-6M | · | · | · | $-7M | · | · | · | $-16M | · | · |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1582.5% | -1967.1% | · | -162340.8% | · | -18016.8% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| Net Margin | -1590.4% | -1967.7% | · | -157505.1% | · | -17219.1% | · | -11279.4% | 57539.3% | -72622.6% | · | -829.9% | · | · | · | · | |
| EBITDA Margin | -1582.5% | -1603.3% | · | -162340.8% | · | -17394.9% | · | -11228.7% | -32799.1% | -64743.8% | · | -839.6% | · | · | · | · | |
| ROA | -16.9% | -12.9% | · | -14.6% | -22.0% | -27.7% | · | -21.8% | 55.1% | -31.1% | · | -22.0% | -23.5% | -20.2% | · | -14.1% | |
| ROE | 44.9% | 68.0% | · | -518.8% | 79.8% | 42.6% | · | 249.3% | -53911.2% | 224.1% | · | -69.0% | -57.8% | -44.9% | · | -24.1% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.0 | · | 1.2 | 0.3 | 0.6 | · | 1.1 | 1.4 | 0.6 | · | 0.9 | 0.9 | 1.2 | · | 2.2 | |
| Quick Ratio | 0.7 | 0.9 | · | 1.1 | 0.3 | 0.5 | · | 0.9 | 1.1 | 0.2 | · | 0.5 | 0.5 | 0.8 | · | 1.8 | |
| Debt / Equity | · | · | · | 0.0 | -0.0 | -0.0 | · | · | · | · | · | · | · | · | · | · |
Eficiência 1
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | 0.0 |
Avaliação (TTM) 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | $98.9K | $98.9K | · | $1M | $1M | $1M | · | $1M | $10M | · | · | · | |
| Net Income TTM | $-14M | $-15M | · | $-17M | $-186.6K | $-3M | · | $-7M | $-11M | $-32M | · | $-32M | $-23M | $-23M | · | $-28M | |
| Market Cap | $32M | $26M | · | $29M | $22M | $26M | · | $28M | $34M | $591M | · | $545M | $946M | $1.08B | · | $1.01B | |
| Enterprise Value | · | · | · | $6M | $17M | $15M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.9 | -1.3 | · | -1.2 | 119.5 | -8.5 | · | -3.5 | -2.5 | -1.8 | · | -2.2 | -7.9 | -46.2 | · | -33.3 | |
| P/S | · | · | · | · | 218.3 | 258.7 | · | 25.8 | 33.4 | 586.0 | · | 544.9 | 94.6 | · | · | · | |
| P/B | -57.1 | 36.1 | · | 10.2 | -1.7 | -2.7 | · | -18.7 | 12.9 | -53.8 | · | -238.1 | -347.9 | 216.3 | · | 38.2 | |
| P / Tangible Book | · | 36.1 | · | 10.2 | · | · | · | · | 12.9 | · | · | · | · | 216.3 | · | 38.2 | |
| P / Cash Flow | · | -4.8 | · | · | · | -4.7 | · | · | · | -86.8 | · | · | · | -66.7 | · | · | |
| P / FCF | · | -4.8 | · | · | · | -4.5 | · | · | · | -86.7 | · | · | · | -66.7 | · | · | |
| EV / EBITDA | · | · | · | -1.7 | -4.4 | -3.5 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -2.7 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 169.3 | 155.2 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.0% | -79.1% | · | -84.8% | 0.84% | -11.8% | · | -28.7% | -39.7% | -54.6% | · | -44.7% | -12.7% | -2.2% | · | -3.0% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $1M | $9.8K | $3M | $10M | $0 |
| Margem Operacional % | -1315.5% | -239692.2% | -1101.9% | -313.9% | — |
| Lucro líquido | $-13M | $-4M | $-30M | $-31M | $-39M |
| EPS Diluído | $-1.20 | $-0.48 | $-4.15 | $-0.37 | $-0.63 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | — | — | — | 0.0 |
| Índice de liquidez corrente | 1.1 | 0.9 | 0.9 | 1.4 | 3.4 |
| Índice de Liquidez Seca | 1.0 | 0.7 | 0.5 | 1.1 | 3.2 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-10M | $5M | $-39M | $-18M | $-29M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 29 declarantes · $3.8M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 10 (+6 vs trimestre anterior) | 5 (-3 vs trimestre anterior) | 9 (+4 vs trimestre anterior) | 4 (+1 vs trimestre anterior) | +733K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.352.250 | 640.877 | 35,63% | Ações |
| VANGUARD GROUP INC | $876.558 | 454.175 | 23,10% | Ações |
| AMH Equity Ltd | $487.983 | 232.373 | 12,86% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $273.036 | 129.379 | 7,19% | Ações |
| US BANCORP \DE\ | $255.141 | 120.920 | 6,72% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $192.578 | 91.269 | 5,07% | Ações |
| STATE STREET CORP | $100.046 | 47.415 | 2,64% | Ações |
| NORTHERN TRUST CORP | $72.181 | 34.209 | 1,90% | Ações |
| TWO SIGMA ADVISERS, LP | $34.547 | 17.900 | 0,91% | Ações |
| LPL Financial LLC | $31.416 | 14.889 | 0,83% | Ações |
| StoneX Group Inc. | $24.745 | 11.153 | 0,65% | Ações |
| Objectivity Squared, LLC | $23.031 | 10.915 | 0,61% | Ações |
| Farther Finance Advisors, LLC | $19.940 | 9.450 | 0,53% | Ações |
| UBS Group AG | $14.369 | 6.810 | 0,38% | Ações |
| JANE STREET GROUP, LLC | $14.133 | 6.698 | 0,37% | Ações |
| BlackRock, Inc. | $6.284 | 2.978 | 0,17% | Ações |
| Vanguard Global Advisers, LLC | $6.203 | 2.940 | 0,16% | Ações |
| Bay Harbor Wealth Management, LLC | $2.865 | 1.358 | 0,08% | Ações |
| RAYMOND JAMES FINANCIAL INC | $2.064 | 978 | 0,05% | Ações |
| IFS Advisors, LLC | $2.004 | 950 | 0,05% | Ações |
| SBI Securities Co., Ltd. | $1.361 | 645 | 0,04% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $828 | 396 | 0,02% | Ações |
| Caitong International Asset Management Co., Ltd | $557 | 264 | 0,01% | Ações |
| BARCLAYS PLC | $523 | 248 | 0,01% | Ações |
| CALDWELL SUTTER CAPITAL, INC. | $211 | 100 | 0,01% | Ações |
| MATHER GROUP, LLC. | $177 | 84 | 0,00% | Ações |
| HRT FINANCIAL LP | $47 | 22.430 | 0,00% | Ações |
| Virtu Financial LLC | $33 | 15.803 | 0,00% | Ações |
| PRICE T ROWE ASSOCIATES INC /MD/ | $29 | 13.318 | 0,00% | Ações |
Executivos da empresa 30 insiders · 13 diretores · 17 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Christopherd T Guiffre | Chief Executive Officer | 6 de Janeiro de 2017 A | 12.489 | 0 | 0 | $0 |
| Oliver Fetzer | President and CEO | 24 de Junho de 2014 A | 30.000 | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Chief Financial Officer | 24 de Janeiro de 2023 A | 443.512 | 0 | 0 | $0 |
| Gregg Beloff | CFO | 5 de Janeiro de 2017 A | — | 0 | 0 | $0 |
| Sabrina Martucci Johnson | Chef Executive Officer | 18 de Fevereiro de 2026 A | 962.062 | 0 | 0 | $0 |
| Mardee Haring-Layton | Chief Accounting Officer | 4 de Setembro de 2025 A | — | 0 | 0 | $0 |
| John A Fair | Chief Commercial Officer | 12 de Março de 2024 A | — | 0 | 0 | $0 |
| Scott Eliasof | SVP, Chief Scientific Officer | 5 de Janeiro de 2017 A | — | 0 | 0 | $0 |
| Alejandra Carvajal | VP, General Counsel | 5 de Janeiro de 2017 A | — | 0 | 0 | $0 |
| Adrian Senderowicz | SVP, Chief Medical Officer | 5 de Janeiro de 2017 A | — | 0 | 0 | $0 |
| James E Oneill | Principal Accounting Officer | 5 de Janeiro de 2017 A | 2.098 | 0 | 0 | $0 |
| Karen Lynn Roberts | Sr VP Finance & Administrat | 5 de Fevereiro de 2015 A | — | 0 | 0 | $0 |
| Edward Graeme Garmey | Sr. VP, Chief Medical Officer | 5 de Fevereiro de 2015 A | — | 0 | 0 | $0 |
| Jessica D. Grossman | Conselheiro | 30 de Junho de 2026 A | 26.066 | 0 | 0 | $0 |
| Gregory W Matz | Conselheiro | 30 de Junho de 2026 A | 30.847 | 0 | 0 | $0 |
| Susan L. Kelley | Conselheiro | 30 de Junho de 2026 A | 23.696 | 0 | 0 | $0 |
| Robin Joan Steele | Conselheiro | 30 de Junho de 2026 A | 47.055 | 0 | 0 | $0 |
| William H Rastetter | Conselheiro | 30 de Junho de 2026 A | 39.721 | 0 | 0 | $0 |
| Sophia Nnenna Ononye-Onyia | Conselheiro | 21 de Junho de 2023 A | — | 0 | 0 | $0 |
| Cheryl R Blanchard | Conselheiro | 21 de Junho de 2023 A | — | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Conselheiro | 3 de Abril de 2017 A | 18.819 | 0 | 0 | $0 |
| Stuart A Arbuckle | Conselheiro | 3 de Janeiro de 2017 A | 13.104 | 0 | 0 | $0 |
| David Ross Parkinson | Conselheiro | 3 de Janeiro de 2017 A | 28.488 | 0 | 0 | $0 |
| William Mckee | Conselheiro | 3 de Janeiro de 2017 A | 3.418 | 0 | 0 | $0 |
| David R Walt | Conselheiro | 3 de Janeiro de 2017 A | 193.700 | 0 | 0 | $0 |
| Alan L Crane | Conselheiro | 22 de Junho de 2016 A | 4.771.739 | 0 | 0 | $0 |
| Steven Edward Hall | Conselheiro | 26 de Junho de 2015 A | 2.356.227 | 0 | 0 | $0 |
| CVF, LLC | Detentor de 10% | 7 de Abril de 2015 P | 2.592.577 | 0 | 0 | $0 |
| Roger Hawley | — | 13 de Junho de 2019 A | 944.956 | 0 | 0 | $0 |
| Rock Springs Capital Management LP | — | 15 de Abril de 2014 C | 464.365 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 8 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Roger L. Hawley, The Hawley Family Trust Dated October 22, 2004 ×4 declarações | 1 de Abril de 2020 | — | Declaração inicial | — | SEC |
| Sabrina Martucci Johnson, Vincent S. Johnson and Sabrina M. Johnson Family Trust Dated February 14, 2005, Vincent S. Johnson ×3 declarações | 21 de Fevereiro de 2020 | — | Declaração inicial | — | SEC |
| Mark Walters, Walters Family Trust Dated January 15, 2009, Nancy Walters ×2 declarações | 16 de Abril de 2019 | — | Declaração inicial | — | SEC |
| Lisa Walters-Hoffert, Lisa Walters-Hoffert Survivor’s Trust dated October 31, 2002 ×2 declarações | 15 de Abril de 2019 | — | Declaração inicial | — | SEC |
| Polaris Venture Partners IV, L.P. (“PVP IV”), Polaris Venture Partners Entrepreneurs’ Fund IV, L.P. (“PVPE IV”), Polaris Venture Management Co. IV, L.L.C. (“PVM IV”), Jonathan A. Flint, Terrance G. McGuire ×2 declarações | 14 de Fevereiro de 2019 | — | Declaração inicial | — | SEC |
| Alan Crane ×2 declarações | 14 de Fevereiro de 2019 | — | Declaração inicial | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 declarações | 14 de Fevereiro de 2019 | — | Declaração inicial | — | SEC |
| Daré Bioscience, Inc. | 28 de Março de 2017 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 3 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.